Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This group represents a complex network of reactive chemical species and ions that drive oxidative and carbonyl stress within biological systems. Reactive oxygen species (ROS), such as superoxide and hydrogen peroxide, and redox-active metal ions like iron and copper interact via the Fenton and Haber-Weiss reactions to generate highly damaging hydroxyl radicals, which initiate lipid peroxidation and protein oxidation (Halliwell & Gutteridge, Free Radicals in Biology and Medicine). These processes produce reactive carbonyl compounds (RCCs), such as methylglyoxal and malondialdehyde, which further react with proteins and nucleic acids to form permanent, cross-linked structures known as advanced glycation end products (AGEs) (PubMed: 11882507). The accumulation of these species is a hallmark of chronic inflammatory conditions, including diabetes, neurodegeneration, and cardiovascular disease, where they cause structural damage to the extracellular matrix and trigger pro-inflammatory signaling through receptors like RAGE (NIH/PMC: PMC3583887). Therapeutic strategies involve the use of antioxidants like Edaravone to scavenge ROS, chelating agents like Deferoxamine to sequester metal ions, and carbonyl traps to prevent the formation of AGEs, although maintaining the balance of physiological redox signaling remains a significant clinical challenge (StatPearls: NBK537044).
Free radical scavenging, metal ion chelation, inhibition of glycation, neutralization of reactive carbonyls, and prevention of oxidative damage to cellular components.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species, reactive carbonyl compounds, advanced glycation end products, and redox-active metal ions (ROS/RCC/AGE/Metal ions).